TRE atment of AT opic eczema ( TREAT ) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and systemic therapy registries-Reference-Cited by-同舟云学术

TRE atment of AT opic eczema ( TREAT ) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and systemic therapy registries

Published:2018-08-03 Issue:4 Volume:180 Page:790-801
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Gerbens L.A.A.¹^ORCID,Apfelbacher C.J.²^ORCID,Irvine A.D.³⁴⁵^ORCID,Barbarot S.⁶^ORCID,Booij R.J.⁷,Boyce A.E.⁸,Deleuran M.⁹,Eichenfield L.F.¹⁰,Hof M.H.¹¹,Middelkamp‐Hup M.A.¹,Roberts A.⁷¹²,Schmitt J.¹³¹⁴^ORCID,Vestergaard C.⁹,Wall D.³¹⁵,Weidinger S.¹⁶,Williamson P.R.¹⁷,Flohr C.⁸^ORCID,Spuls P.I.¹^ORCID,

Affiliation:

1. Department of Dermatology Academic Medical Center University of Amsterdam Meibergdreef 9 1105 AZ Amsterdam the Netherlands

2. Medical Sociology Institute of Epidemiology and Preventive Medicine University of Regensburg Regensburg Germany

3. Department of Paediatric Dermatology Our Lady's Children's Hospital Crumlin, Dublin Ireland

4. Department of Clinical Medicine Trinity College Dublin Dublin Ireland

5. National Children's Research Centre Dublin Ireland

6. Department of Dermatology Nantes University Hospital Nantes France

7. Contributing patient

8. Unit for Population‐Based Dermatology Research St John's Institute of Dermatology, Guy's & St Thomas’ NHS Foundation Trust and King's College London London U.K

9. Department of Dermatology and Venereology Aarhus University Hospital Aarhus Denmark

10. Departments of Dermatology and Pediatrics University of California San Diego CA U.S.A

11. Department of Clinical Epidemiology, Biostatistics, and Bioinformatics Academic Medical Centre Amsterdam the Netherlands

12. Nottingham Support Group for Carers of Children with Eczema Nottingham U.K

13. Center for Evidence‐based Healthcare Medizinische Fakultät Carl Gustav Carus, TU Dresden Dresden Germany

14. University Allergy Center University Hospital Carl Gustav Carus Dresden Germany

15. Irish Skin Foundation Dublin Ireland

16. Department of Dermatology and Allergy University Hospital Schleswig‐Holstein Campus Kiel Kiel Germany

17. MRC North West Hub for Trials Methodology Research Department of Biostatistics University of Liverpool Liverpool U.K

Funder

Carsten Flohr

Phyllis Spuls

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.16714

Reference28 articles.

1. Atopic dermatitis

2. European Medicines Agency.Questions and answers on Sandimmun Sandimmun Neoral and associated names (ciclosporin 10 25 50 and 100 mg capsules 100 mg/ml oral solution and 50 mg/ml concentrate for solution for infusion).2013. Available at:www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Sandimmun_30/WC500144897.pdf(last accessed 9 May 2018).

3. U.S. Food and Drug Administration (FDA).FDA approves new eczema drug Dupixent. 28 March 2017. Available at:https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm549078.htm(last accessed 9 May 2018).

4. European Medicines Agency.Dupixent.2017. Available at:http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004390/human_med_002158.jsp&mid=WC0b01ac058001d124(last accessed 9 May 2018).

5. The European treatment of severe atopic eczema in children taskforce (TREAT) survey

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry;British Journal of Dermatology;2024-07-15

2. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study;JAMA Dermatology;2024-03-01

3. Hohe Rezidivrate des Eczema herpeticatum bei mittelschwerer bis schwerer atopischer Dermatitis – eine TREATgermany Registeranalyse;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-12

4. Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry;Journal of the European Academy of Dermatology and Venereology;2023-11-29

5. A core domain set for pyoderma gangrenosum trial outcomes - an international e-Delphi and consensus study from the UPGRADE initiative;British Journal of Dermatology;2023-11-11